Internist Shirin Peters, M.D. of Bethany Medical Clinic Shares Back-to-College Health Tips and Tricks

NEW YORK–(BUSINESS WIRE)–Summer is winding down and college students across the country are settling into their dorms and new class schedule for the fall semester. As routines and in some cases climates change drastically for these students, Shirin Peters, M.D., Founder of Bethany Medical Clinic, offers her tips to help college students ensure they keep … [Read more…]

Genome Insight and Ajou University Medical Center Launch Program to Apply Whole Genome Sequencing for Routine Cancer Care

SAN DIEGO–(BUSINESS WIRE)–Genome Insight, a cancer whole genome platform company, is launching a pilot program in Ajou University Medical Center to test the use of Whole Genome Sequencing (WGS) in routine cancer care setting. Cancer patients at various stages in the treatment journey will be eligible to receive WGS testing if the clinician notices potential … [Read more…]

Virtis Health Unveils Ambulatory Infusion Center in Houston

Clinical Expertise and Advanced Therapies Cater to Growing Patient Population HOUSTON–(BUSINESS WIRE)–#VirtisHealthAmbulatoryInfusionCenters—Virtis Health, a national healthcare provider dedicated to therapeutic and diagnostic services for patients with complex conditions requiring specialty infusible and injectable medications, announced today its unveiling of an ambulatory infusion center (AIC) in Houston. Virtis Health Houston is conveniently located at 6800 West … [Read more…]

NewAmsterdam Pharma Showcases Leadership in Cardiometabolic Disease Treatment in Multiple Presentations at ESC Congress 2022

— Emerging data reinforce combination lipid-lowering therapy as first-line strategy for very high-risk patients, supporting the development of obicetrapib as adjunct to high-intensity statins — NAARDEN, Netherlands & MIAMI–(BUSINESS WIRE)–NewAmsterdam Pharma (NewAmsterdam Pharma), a clinical-stage company focused on the research and development of transformative oral therapies for metabolic diseases, today announced emerging data adding to … [Read more…]

Teva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir® Digihaler® (albuterol sulfate) Inhalation Powder at the European Respiratory Society (ERS) International Congress 2022

The study evaluated the effect of the ProAir Digihaler System on asthma control versus standard of care as measured by the Asthma Control Test, and explored use of the ProAir Digihaler System to help support patient-physician interactions for asthma management versus standard of care TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva Pharmaceuticals USA, Inc., a … [Read more…]

Shape Memory Medical Completes Enrollment in the AAA-SHAPE Early Feasibility Study

SANTA CLARA, Calif.–(BUSINESS WIRE)–#AAA–Shape Memory Medical Inc., developer of custom, proprietary shape memory polymers for the peripheral and neurovascular markets, announced the completion of patient enrollment in AAA-SHAPE, the Company’s prospective, multicenter early feasibility safety study of the IMPEDE-FX RapidFill® Device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair … [Read more…]

Tranquis Therapeutics to Present Preclinical Data on TQS-168 at ARDD 2022

-TQS-168 demonstrated robust geroprotective effects in preclinical studies- REDWOOD CITY, Calif.–(BUSINESS WIRE)–Tranquis Therapeutics, Inc., a clinical stage immuno-neurology company developing innovative medicines with the potential to revolutionize the management of neurodegenerative and aging-related diseases, today announced it will present preclinical data on the anti-aging effects of TQS-168, a small molecule modulator of PGC-1a, at ARDD … [Read more…]

Alnylam Reports Positive Results from Phase 2 Study of Investigational Cemdisiran for the Treatment of IgA Nephropathy

-Treatment with Cemdisiran Resulted in a Higher Proportion of Patients Achieving Clinically Meaningful Reductions in 24-Hour Urine Protein to Creatinine Ratio, as Compared to Patients on Placebo – – Consistent Proteinuria Reduction Seen with Secondary Endpoints – – Cemdisiran Was Generally Well-Tolerated in Patients with IgA Nephropathy – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) … [Read more…]

Acorda Therapeutics Enters into License Agreement with Asieris Pharmaceuticals

PEARL RIVER, N.Y.–(BUSINESS WIRE)–Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has entered into a license agreement relating to its preclinical asset, Nepicastat, with Asieris Pharmaceuticals, a biotechnology company headquartered in China. Under the terms of the agreement, Acorda will receive an upfront payment of $500,000, and up to an additional $7 million based … [Read more…]

Levine Leichtman Capital Partners Sells Monte Nido

LOS ANGELES–(BUSINESS WIRE)–Levine Leichtman Capital Partners (“LLCP”), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company Monte Nido & Affiliates (“Monte Nido” or the “Company”) to funds managed by Revelstoke Capital Partners LLC. Financial terms of the transaction were not disclosed. Founded in 1996, Monte Nido is a leading … [Read more…]